Ke Chen

Years Active: 2019-2024
Publications (10 Years): 5

Huazhong University of Science and Technology

Wuhan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Huazhong University of Science and Technology Sep 30 2013

China

Associate Researcher :: Department of Urology, Tongji Hospital

University of Illinois at Chicago Cancer Center Jul 01 2016 - Jun 01 2017

United States

postdoctoral :: Medical school

Case Western Reserve University Apr 26 2016 - Jul 01 2016

United States

postdoctoral :: Department of Genetics & Genome Sciences

Education History

Wuhan University Sep 01 2006 - Jun 30 2013

China

PHD :: Life Science

Publications

Siquan Ma, Yi Sun, Guoyao Gao, Jin Zeng, Ke Chen, Zhenyu Zhao
The ubiquitin ligase STUB1 suppresses tumorigenesis of renal cell carcinomas through regulating YTHDF1 stability. Carcinogenesis (2024)
Wenbo Chen, Xin Chen, Zhenyu Zhao, Menglu Li, Shuang Dong, Sheng Hu, Xiaoyu Li, Mingqian Feng, Ke Chen, Shan Zhong, Chunjiang He
Pan-Cancer Identification of Prognostic-Associated Metabolic Pathways. Biology 12 (8) (2023)
Gongwei Long, Siquan Ma, Runlin Shi, Yi Sun, Zhiquan Hu, Ke Chen
Circular RNAs and Drug Resistance in Genitourinary Cancers: A Literature Review. Cancers 14 (4) (2022)
Zhiquan Hu, Siquan Ma, Yi Sun, Gongwei Long, Ke Chen
Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer. Genes 13 (8) (2022)
Jin Zeng, Wei Xiang, Yucong Zhang, Chunhua Huang, Ke Chen, Zhiqiang Chen
Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma. BMC cancer 19 (1) (2019)

Ke Chen.css-eqlu8i{font-size:small;padding-left:4px;}